-> Contact Us    -> Site Map   
  -> Search
ImmunoGen, Inc.
Company OverviewOur TAP TechnologyProduct PipelineInvestor InformationJoin Our Team
ImmunoGen, Inc.
Targeted Therapies for Cancer

ImmunoGen, Inc. develops targeted anticancer therapeutics. Our proprietary Targeted Antibody Payload (TAP) technology and strong antibody expertise form the basis for our development of our own products as well as of our partnerships with other companies.

Product Pipeline

Multiple compounds are in the clinic through our own programs and those of our partners.

-> Learn more about them...

TAP Technology

Numerous presentations on TAP compounds have recently been made at medical meetings.

-> Find information about these...

built@zoomedia.com © 2010 ImmunoGen, Inc. | Privacy Policy | Usage Policy
Last updated February 3, 2010